Cargando…

A case report of traditional Korean medicine treatments on uterine myoma with thyroid cancer

Uterine myoma is a common benign tumor. When the symptoms are not severe, patients are often suggested to wait for menopause without treatment. If the size becomes too large or the symptoms get worse, the patient will receive surgery or hormone therapy. If a patient does not receive surgery or hormo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Chae-Hak, Yoo, Jeong-Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251281/
https://www.ncbi.nlm.nih.gov/pubmed/30505680
http://dx.doi.org/10.1016/j.imr.2018.10.003
_version_ 1783373091106193408
author Lim, Chae-Hak
Yoo, Jeong-Eun
author_facet Lim, Chae-Hak
Yoo, Jeong-Eun
author_sort Lim, Chae-Hak
collection PubMed
description Uterine myoma is a common benign tumor. When the symptoms are not severe, patients are often suggested to wait for menopause without treatment. If the size becomes too large or the symptoms get worse, the patient will receive surgery or hormone therapy. If a patient does not receive surgery or hormone therapy because of the waiting period, traditional Korean medicine (TKM) treatment can be applied. This is a case of a 47-year-old woman who was diagnosed with thyroid cancer and uterine myoma. She was diagnosed with thyroid cancer in 2012 and uterine myoma in 2013. She had not received treatments. In December 2017, the size of the uterine myoma increased to more than 8 cm, and the patient suffered from dysmenorrhea, urination frequency, and vaginal discharges. She wanted TKM treatment instead of surgery or hormone therapy. From January 16, 2018 to April 12, 2018, she received TKM treatment; herbal medicine, acupuncture, moxibustion, and pharmacopuncture. Before the treatment, the urination frequency was more than 10 times a day, but decreased to 6–7 times a day after treatments. Dysmenorrhea decreased from VAS8 to VAS5 after treatments. After menstruation, the duration of vaginal secretion persisted for 3–4 days, but after treatments, it was visible only for a 1 day after menstruation. Ultrasonography showed that the thyroid cancer did not worsen and the size of uterine myoma decreased by 2 cm. It is considered that TKM treatment, as a substitute for surgery or hormone therapy, will exert positive effect on uterine myoma without the aggravation of thyroid cancer.
format Online
Article
Text
id pubmed-6251281
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-62512812018-11-30 A case report of traditional Korean medicine treatments on uterine myoma with thyroid cancer Lim, Chae-Hak Yoo, Jeong-Eun Integr Med Res Case Report Uterine myoma is a common benign tumor. When the symptoms are not severe, patients are often suggested to wait for menopause without treatment. If the size becomes too large or the symptoms get worse, the patient will receive surgery or hormone therapy. If a patient does not receive surgery or hormone therapy because of the waiting period, traditional Korean medicine (TKM) treatment can be applied. This is a case of a 47-year-old woman who was diagnosed with thyroid cancer and uterine myoma. She was diagnosed with thyroid cancer in 2012 and uterine myoma in 2013. She had not received treatments. In December 2017, the size of the uterine myoma increased to more than 8 cm, and the patient suffered from dysmenorrhea, urination frequency, and vaginal discharges. She wanted TKM treatment instead of surgery or hormone therapy. From January 16, 2018 to April 12, 2018, she received TKM treatment; herbal medicine, acupuncture, moxibustion, and pharmacopuncture. Before the treatment, the urination frequency was more than 10 times a day, but decreased to 6–7 times a day after treatments. Dysmenorrhea decreased from VAS8 to VAS5 after treatments. After menstruation, the duration of vaginal secretion persisted for 3–4 days, but after treatments, it was visible only for a 1 day after menstruation. Ultrasonography showed that the thyroid cancer did not worsen and the size of uterine myoma decreased by 2 cm. It is considered that TKM treatment, as a substitute for surgery or hormone therapy, will exert positive effect on uterine myoma without the aggravation of thyroid cancer. Elsevier 2018-12 2018-10-25 /pmc/articles/PMC6251281/ /pubmed/30505680 http://dx.doi.org/10.1016/j.imr.2018.10.003 Text en © 2018 Korea Institute of Oriental Medicine. Published by Elsevier. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Lim, Chae-Hak
Yoo, Jeong-Eun
A case report of traditional Korean medicine treatments on uterine myoma with thyroid cancer
title A case report of traditional Korean medicine treatments on uterine myoma with thyroid cancer
title_full A case report of traditional Korean medicine treatments on uterine myoma with thyroid cancer
title_fullStr A case report of traditional Korean medicine treatments on uterine myoma with thyroid cancer
title_full_unstemmed A case report of traditional Korean medicine treatments on uterine myoma with thyroid cancer
title_short A case report of traditional Korean medicine treatments on uterine myoma with thyroid cancer
title_sort case report of traditional korean medicine treatments on uterine myoma with thyroid cancer
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251281/
https://www.ncbi.nlm.nih.gov/pubmed/30505680
http://dx.doi.org/10.1016/j.imr.2018.10.003
work_keys_str_mv AT limchaehak acasereportoftraditionalkoreanmedicinetreatmentsonuterinemyomawiththyroidcancer
AT yoojeongeun acasereportoftraditionalkoreanmedicinetreatmentsonuterinemyomawiththyroidcancer
AT limchaehak casereportoftraditionalkoreanmedicinetreatmentsonuterinemyomawiththyroidcancer
AT yoojeongeun casereportoftraditionalkoreanmedicinetreatmentsonuterinemyomawiththyroidcancer